Ramelteon improves blood-brain barrier of focal cerebral ischemia rats to prevent post-stroke depression via upregulating occludin
Behavioural Brain Research · 2023
DOI: 10.1016/j.bbr.2023.114472 ↗Kurz gefasst
Fachartikel in der Zeitschrift Behavioural Brain Research, 2023. Verfasst von Xuchen Qi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China. Hauptthemen laut MEDLINE: Stroke, Brain Ischemia, Reperfusion Injury. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Depression, Schlaganfall
Abstract (Originalsprache)
Post-stroke depression (PSD) negatively affects the prognosis of post-stroke animals. Ramelteon has neuroprotection for chronic ischemia animals, but the effect and the biological mechanism of it on PSD is still unclear. This study explored the effects of ramelteon with prophylactic administration on blood-brain barrier in rats with middle cerebral artery occlusion (MCAO) and the oxygen-glucose deprivation/reperfusion (OGD/R) bEnd.3 cells and found that ramelteon pretreatment improved the depressive-like behaviors and decreased infarct area in MCAO rats. Also, this study found ramelteon pretreatment improved viability and inhibited permeability in OGD/R cells. In addition, this study found that MCP-1, TNF-α, and IL-1 levels were raised in the MCAO rats and that occludin protein and mRNA levels were decreased in the MCAO and the OGD/R models, while the Egr-1 level was up-regulated. All of these were antagonized by ramelteon pretreatment. In addition, overexpression of Egr-1 could reverse the effect of 100 nM ramelteon pretreatment on FITC and occludin levels in OGD/R cells. In short, this study has demonstrated that the protective effect on PSD of ramelteon pretreatment on MCAO rats is related to the development of BBB permeability and that ramelteon regulates occludin to protect the BBB by inhibiting Egr-1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
- Department of Psychology, New York University, New York, United States.
- Medical Research Center, Shaoxing People's Hospital, Zhejiang University Shaoxing Hospital, Shaoxing, China.
- Department of Neurology, Shaoxing People's Hospital, Zhejiang University Shaoxing Hospital, Shaoxing, China.
- Department of Neurosurgery, Shaoxing People's Hospital, Zhejiang University Shaoxing Hospital, Shaoxing, China.
- Department of Traditional Chinese Medicine, Shaoxing People's Hospital, Zhejiang University Shaoxing Hospital, Shaoxing, China. Electronic address: 42879587@qq.com.
Zitieren
APA
Qi, X., Tang, Z., Shao, X., Wang, Z., Li, M., Zhang, X., He, L., Wang, J., & Yu, X. (2023). Ramelteon improves blood-brain barrier of focal cerebral ischemia rats to prevent post-stroke depression via upregulating occludin. Behavioural Brain Research. https://doi.org/10.1016/j.bbr.2023.114472
Vancouver
Qi X, Tang Z, Shao X, Wang Z, Li M, Zhang X, et al. Ramelteon improves blood-brain barrier of focal cerebral ischemia rats to prevent post-stroke depression via upregulating occludin. Behavioural Brain Research. 2023. doi:10.1016/j.bbr.2023.114472
BibTeX
@article{Qi2023,
author = {Qi, Xuchen and Tang, Ziqi and Shao, Xian and Wang, Zhaowei and Li, Mengyun and Zhang, Xiaobing and He, Lingyan and Wang, Jianli and Yu, Xuebin},
title = {Ramelteon improves blood-brain barrier of focal cerebral ischemia rats to prevent post-stroke depression via upregulating occludin},
journal = {Behavioural Brain Research},
year = {2023},
doi = {10.1016/j.bbr.2023.114472}
}
EUVIMED